help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 1, 2004, doi:10.1165/rcmb.2003-0440OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0440OCv1
31/2/154    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cruz, A. C.
Right arrow Articles by Fang, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruz, A. C.
Right arrow Articles by Fang, K. C.
American Journal of Respiratory Cell and Molecular Biology. Vol. 31, pp. 154-161, 2004
© 2004 American Thoracic Society
DOI: 10.1165/rcmb.2003-0440OC

Induction of Mast Cell Activation and CC Chemokine Responses in Remodeling Tracheal Allografts

Anthony C. Cruz, Timothy S. Hall, Kirk D. Jones, Samuel T. Edwards and Kenneth C. Fang

Cardiovascular Research Institute, and Departments of Medicine, Surgery, and Pathology, University of California, San Francisco, California

Address correspondence to: Dr. Kenneth C. Fang, Box 0911, Cardiovascular Research Institute, University of California, San Francisco, CA 94143-0911. E-mail: kfang{at}itsa.ucsf.edu

Activated mast cells release stored and newly synthesized mediators that influence the caliber and responsiveness of inflamed airways. In this work, we show that alloimmune-mediated mechanisms induce mast cell activation and expression of CC chemokines in remodeling rat tracheal allografts. Decreased expression of rat mast cell protease (RMCP) I and II, in concert with tryptase release in tracheal allografts, identified degranulation of stored serine proteases as an early mast cell response to allotransplantation. Transient upregulation of c-Kit expression occurred in a synchronous manner, suggesting that c-Kit receptor signaling controls mast cell responses. Increased expression of CC chemokine ligand (CCL) 2 and CCL3 by RMCP I–positive cells identified mast cells as epithelial and mesenchymal sources of chemoattractant chemokines in allograft airways. Cyclosporin A immunosuppression both attenuated and delayed these changes in mast cell phenotypes. Incubation of rat basophil leukemia 2H3 cells with CCL2 or CCL3 decreased surface c-Kit expression, an effect blocked by protease inhibitors. By controlling surface receptor availability, CC chemokines may regulate c-Kit signaling via a novel proteolytic mechanism. These data suggest that targeting alloimmune responses and restoring quiescence of mast cells may attenuate the development of fibroproliferative and obstructive distortions of bronchiolar architecture in lung allografts.

Abbreviations: c-Kit receptor tyrosine kinase, c-Kit • CC chemokine ligand, CCL • cyclosporin A, CSA • c-Kit ligand, KL • macrophage/monocyte chemoattractant protein-1, MCP-1 • macrophage inhibitory protein-1{alpha}, MIP-1{alpha} • obliterative bronchiolitis, OB • phosphate-buffered saline, PBS • paraformaldehyde, PFA • rat basophil leukemia, RBL • rat mast cell protease, RMCP • tracheal lavage fluid, TLF







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2004 American Thoracic Society.
  ATS Coding and Billing Quarterly